eta2 Antibody

What is Ets2 and what cellular functions does it regulate?

Ets2 (E26 transformation-specific sequence 2) is a transcription factor that binds specifically to the DNA GGAA/T core motif (Ets-binding site or EBS) in gene promoters and stimulates transcription . Research demonstrates that Ets2 plays a significant role in regulating inflammatory responses. It negatively regulates LPS and vesicular stomatitis virus (VSV)-induced proinflammatory cytokine production in macrophages. Studies have shown that Ets2 inhibits the production of inflammatory cytokines such as IL-6, TNF-α, and IFN-β, suggesting its importance in maintaining inflammatory homeostasis .

What are the typical applications for Ets2 antibodies in research?

Ets2 antibodies are commonly used in multiple research applications including Western Blot (WB), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunohistochemistry (IHC-P), and Immunoprecipitation (IP) . These antibodies are particularly valuable for investigating Ets2's role in immune response regulation, inflammatory pathways, and transcriptional activation. When studying Ets2's function in inflammatory processes, researchers typically monitor changes in cytokine production through techniques like ELISA and qPCR following experimental manipulation of Ets2 expression .

How do I select the appropriate Ets2 antibody for my experiment?

When selecting an Ets2 antibody, consider the following methodological factors:

• Target species compatibility: Verify that the antibody recognizes your species of interest (human, mouse, rat, etc.)

• Antibody type: Determine whether a monoclonal or polyclonal antibody is more suitable for your application

• Validated applications: Confirm the antibody has been validated for your specific application (WB, ICC/IF, IHC-P, IP)

• Epitope location: Consider whether you need an antibody that targets the N-terminal, middle region, or C-terminal of Ets2

• Modifications detection: Some experiments may require antibodies that can distinguish between phosphorylated and non-phosphorylated forms of Ets2

How does Ets2 mediate inhibition of inflammatory cytokine production at the molecular level?

Ets2 inhibits inflammatory cytokine production through multiple signaling pathways. Mechanistically, research has demonstrated that Ets2 inhibits the LPS- and VSV-induced activation of several key inflammatory signaling components:

• MAPK pathway: Ets2 suppresses the activation of ERK1/2, JNK, and p38

• NF-κB pathway: Ets2 inhibits the activation of p65, a critical component of NF-κB signaling

This dual inhibition results in decreased transcription of proinflammatory cytokines including IL-6 and TNF-α. Knockdown or knockout of Ets2 leads to increased production of these cytokines in macrophages, and Ets2-deficient mice show exacerbated inflammatory cytokine production and increased susceptibility to sepsis . When designing experiments to investigate these pathways, researchers should consider measuring phosphorylation levels of these signaling proteins alongside cytokine production.

What statistical approaches are most appropriate for analyzing antibody-mediated detection of Ets2 in different experimental conditions?

When analyzing antibody-mediated detection of Ets2 across experimental conditions, researchers should consider:

• Parametric vs. non-parametric tests: Depending on data distribution, use t-tests and ANOVA (parametric) or Mann-Whitney and Kruskal-Wallis tests (non-parametric)

• Effect size calculations: Beyond p-values, calculate effect sizes such as Cohen's d or eta squared (η²) to quantify the magnitude of differences

• Correlation analyses: When examining relationships between Ets2 levels and other variables, consider Pearson's r (linear relationships) or Spearman's rho (non-linear relationships)

• Multiple comparisons adjustment: Apply Bonferroni or false discovery rate corrections when performing multiple comparisons

For instance, in studies examining relationships between variables, eta squared (η²) can quantify association strength. In one study examining plasma antibody levels, researchers found a significant association with vaccination status (P = 0.00147, η² = 0.211), indicating a moderate effect size .

How can I optimize immunoprecipitation protocols for detecting Ets2 protein interactions?

Optimizing immunoprecipitation (IP) protocols for Ets2 requires methodological precision:

• Antibody selection: Use validated antibodies specific for IP applications. For example, ab219948 has been validated for Ets2 immunoprecipitation at a 1/30 dilution .

• Lysate preparation: Use lysis buffers that preserve protein-protein interactions while effectively solubilizing membrane-associated proteins.

• Cross-linking considerations: For transient or weak interactions, consider using chemical cross-linking agents.

• Controls: Always include:

  • Input control (typically 5-10% of starting material)

  • Negative control using isotype-matched IgG (e.g., rabbit monoclonal IgG instead of Ets2 antibody)

• Detection strategy: Consider using specialized detection reagents such as VeriBlot for IP Detection Reagent to minimize detection of denatured antibody chains .

• Phosphorylation state: Be aware that Ets2 can exist in phosphorylated and non-phosphorylated forms, which may appear as distinct bands on Western blots following IP .

What are the most effective approaches for studying Ets2's role in inflammatory processes?

When designing experiments to study Ets2's role in inflammation, consider these methodological approaches:

• Gene manipulation strategies:

  • siRNA knockdown: Transfect cells with Ets2-targeted siRNA to reduce expression

  • CRISPR-Cas9: Generate Ets2 knockout cell lines or animal models

  • Overexpression: Transfect cells with Ets2 expression vectors

• Stimulus selection:

  • LPS stimulation (e.g., 100 ng/ml) to activate TLR4 signaling

  • Viral challenges (e.g., VSV) to study antiviral responses

  • CLP (cecal ligation and puncture) for in vivo sepsis models

• Readout measurements:

  • qPCR to measure cytokine mRNA expression (IL-6, TNF-α, IFN-β)

  • ELISA to quantify secreted cytokine proteins

  • Western blotting to assess activation of MAPK and NF-κB pathway components

  • Immunofluorescence to visualize Ets2 localization following stimulation

How can I establish a robust time-course experiment to study Ets2 expression and function after stimulation?

Designing time-course experiments for Ets2 requires careful planning:

• Baseline establishment:

  • Measure Ets2 expression in unstimulated cells as a reference point

  • Include time-matched unstimulated controls for each time point

• Time point selection:

  • Early time points (0, 15, 30 minutes) to capture immediate signaling events

  • Intermediate time points (1, 3, 6 hours) to observe transcriptional changes

  • Later time points (12, 24, 48 hours) to assess downstream effects

• Parallel measurements:

  • Ets2 protein levels by Western blot

  • Ets2 mRNA expression by qPCR

  • Phosphorylation status of Ets2 using phospho-specific antibodies

  • Downstream target gene expression

• Stimulus concentration gradients:

  • Include dose-response elements alongside time course

  • For LPS, typical ranges include 10-1000 ng/ml

How should I interpret discrepancies between Ets2 mRNA expression and protein levels detected by antibodies?

When facing discrepancies between Ets2 mRNA and protein levels, consider these methodological explanations:

• Post-transcriptional regulation:

  • miRNA-mediated suppression of translation

  • Changes in mRNA stability or translation efficiency

• Post-translational modifications:

  • Protein phosphorylation (Ets2 exists in both phosphorylated and non-phosphorylated forms)

  • Ubiquitination and proteasomal degradation affecting protein half-life

• Technical considerations:

  • Antibody epitope accessibility may be affected by protein conformation or complex formation

  • Detection sensitivity differences between qPCR and Western blot techniques

  • Proper normalization to loading controls for both techniques

• Temporal dynamics:

  • Time lag between transcriptional and translational events

  • Different degradation rates of mRNA versus protein

What are the common pitfalls in analyzing Ets2 antibody-generated data, and how can they be avoided?

Common pitfalls in Ets2 antibody data analysis include:

• Non-specific binding:

  • Always include appropriate negative controls

  • Validate antibody specificity using knockout/knockdown samples

  • Consider using multiple antibodies targeting different epitopes

• Signal quantification errors:

  • Use appropriate image analysis software for densitometry

  • Apply background subtraction consistently

  • Establish a linear dynamic range for signal quantification

• Normalization challenges:

  • Select stable reference proteins/genes unaffected by experimental conditions

  • Consider multiple normalization controls when analyzing inflammatory conditions

  • Verify that housekeeping gene expression remains constant under experimental conditions

• Statistical analysis errors:

  • Avoid inappropriate parametric testing with non-normally distributed data

  • Control for multiple comparisons when analyzing multiple time points or conditions

  • Report effect sizes (like eta squared) alongside p-values to indicate biological significance

What strategies can resolve weak or inconsistent Ets2 antibody signals in Western blotting?

When encountering weak or inconsistent Ets2 signals, implement these methodological improvements:

• Sample preparation optimization:

  • Use phosphatase inhibitors to preserve phosphorylated Ets2 forms

  • Optimize lysis buffer composition for complete protein extraction

  • Consider nuclear extraction protocols as Ets2 is a transcription factor

• Antibody optimization:

  • Test multiple antibody concentrations (typical range: 1/500-1/5000 dilution)

  • Extend primary antibody incubation time (overnight at 4°C)

  • Try different blocking agents (BSA vs. non-fat dry milk)

• Detection system enhancement:

  • Consider more sensitive detection systems (enhanced chemiluminescence)

  • Optimize exposure times for digital imaging systems

  • Use signal enhancement systems compatible with your antibody

• Protein loading considerations:

  • Increase protein loading (20-50 μg total protein)

  • Verify transfer efficiency with reversible staining methods

  • Consider concentrating samples with low Ets2 expression

How can I differentiate between phosphorylated and non-phosphorylated forms of Ets2 in my experiments?

Differentiating between Ets2 phosphorylation states requires specific methodological approaches:

• Phospho-specific antibodies:

  • Use antibodies specifically targeting phosphorylated epitopes on Ets2

  • Run parallel blots with phospho-specific and total Ets2 antibodies

• Phosphatase treatment:

  • Treat duplicate samples with lambda phosphatase before SDS-PAGE

  • Compare migration patterns between treated and untreated samples

• Mobility shift assays:

  • Use Phos-tag acrylamide gels to enhance separation of phosphorylated proteins

  • Note that phosphorylated Ets2 typically migrates at a slightly higher apparent molecular weight

• Immunoprecipitation-based approaches:

  • Immunoprecipitate with total Ets2 antibody, then probe with phospho-specific antibodies

  • Two distinct bands representing phosphorylated and non-phosphorylated forms may be visible after immunoprecipitation

What emerging technologies are enhancing Ets2 antibody-based research?

Emerging technologies advancing Ets2 antibody research include:

• Proximity labeling techniques:

  • BioID or TurboID fusion proteins to identify Ets2 interaction partners

  • APEX2-based approaches for spatial proteomics of Ets2 complexes

• Advanced microscopy applications:

  • Super-resolution microscopy for precise Ets2 localization

  • Live-cell imaging with tagged antibody fragments to track Ets2 dynamics

• Single-cell analysis:

  • Antibody-based single-cell proteomics to assess Ets2 heterogeneity

  • Integrated multi-omics approaches combining transcriptomics with antibody-based protein detection

• Antibody engineering advancements:

  • Stability improvement techniques

  • Affinity enhancement methods

  • Half-life extension using anti-serum albumin single-domain antibodies

How might computational approaches improve antibody-based Ets2 research?

Computational approaches enhancing Ets2 antibody research include:

• Molecular modeling and design:

  • Virtual affinity maturation using Assisted Design of Antibody and Protein Therapeutics (ADAPT) platform

  • Computational assessment of antibody developability: stability, immunogenicity, aggregation potential

• Predictive epitope mapping:

  • In silico prediction of optimal Ets2 epitopes for antibody generation

  • Assessment of epitope conservation across species for cross-reactivity prediction

• Machine learning applications:

  • Pattern recognition in antibody binding data to identify optimal detection conditions

  • Automated image analysis for quantifying immunofluorescence or immunohistochemistry results

• Network analysis tools:

  • Integration of Ets2 protein interaction data with transcriptomic responses

  • Pathway enrichment analysis to contextualize Ets2 functional roles in different cell types